Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

A BRET assay for monitoring insulin receptor interactions and ligand pharmacology

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Normal Morning MCH Levels and No Association with REM or NREM Sleep Parameters in Narcolepsy Type 1 and Type 2

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The insulin receptor (IR) belongs to the receptor tyrosine kinase super family and plays an important role in glucose homeostasis. The receptor interacts with several large docking proteins that mediate signaling from the receptor, including the insulin receptor substrate (IRS) family and Src homology-2-containing proteins (Src). Here, we applied the bioluminescence resonance energy transfer 2 (BRET2) technique to study the IR signaling pathways. The interaction between the IR and the substrates IRS1, IRS4 and Shc was examined in response to ligands with different signaling properties. The association between IR and the interacting partners could successfully be monitored when co-expressing green fluorescent protein 2 (GFP2) tagged substrates with Renilla reniformis luciferase 8 (Rluc8) tagged IR. Through additional optimization steps, we developed a stable and flexible BRET2 assay for monitoring the interactions between the IR and its substrates. Furthermore, the insulin analogue X10 was characterized in the BRET2 assay and was found to be 10 times more potent with respect to IRS1, IRS4 and Shc recruitment compared to human insulin. This study demonstrates that the BRET2 technique can be applied to study IR signaling pathways, and that this assay can be used as a platform for screening and characterization of IR ligands.
Original languageEnglish
JournalJournal of Receptors and Signal Transduction
Volume32
Issue number2
Pages (from-to)57-64
ISSN1079-9893
DOIs
Publication statusPublished - 2012

ID: 34679412